Activity approved for 1.5 ASRT Category A Credits
Activity Expires September 1, 2027

Activity Description

This educational session will provide a practical overview of current pharmacologic options for the prevention and treatment of osteoporosis. Participants will review commonly used bone medications and gain a clear understanding of how these therapies differ in their mechanisms of action on bone remodeling. The program will also address expected changes in bone mineral density associated with various treatments, including realistic timelines for achieving clinically meaningful improvement, to support informed decision-making and patient counseling.

Learning Objectives

1. List current bone medications used for osteoporosis prevention and treatment.
2. Differentiate the mechanisms of action of these medications on bone.
3. Describe expected bone density changes and the time intervals required to observe clinically meaningful improvement.

Instructions

Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

Registration Fees

Cancellation Policy

On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.

On-Demand/Enduring Material Program Changes or Cancellations 
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

ASRT Credit Designation 

This activity has been approved by ASRT for 1.5 Category A continuing education credits.

Date of Original Release and most recent Review or Update 

This activity was most recently reviewed and released on August 15th, 2026.

Statement of Independence

The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

Disclaimer

The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

Disclosure of Unlabeled Use 

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Privacy & Confidentiality Statement

The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

Attendee Cancellation Policy

All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.

Course Changes or Cancellations

ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.